Dr. Beth Coyle
PhD Faculty of Medicine, University of Edinburgh
BSc Molecular Biology, University of Edinburgh
Lecturer
Child Health
| Phone: | +44 (0) 115 8230719 |
|---|---|
| Fax: | +44 (0) 115 8230796 |
| Email: | beth.coyle@nottingham.ac.uk |
| Web: | http://www.cbtrc.org/beth_coyle_np |
I have two main areas of research interest. For a number of years I have been investigating the potential of apoptotic mechanisms as therapeutic targets in cancer cells. Several recent studies have identified a population of ‘cancer stem cells’ that are key to the survival of brain and other tumours. Since such cells are also believed to be drug resistant and drug resistance is a major factor in many different types of brain tumour I have established a new project aimed at determining the contribution that drug resistant cancer stem cells make to relapse of paediatric brain tumours.

Dr. Beth Coyle and the Molecular Anaylysis Research Team
Savill R, Somchand N, Joyce K, Scotting PJ and Coyle B (in preparation). The caspase independent apoptotic function of ID2 occurs autonomously of the N terminal domain.
Ridley L, Raman R, Rand V, Brundler MA, Coyle B and Grundy, RJ (in preparation) Prognostic markers in paediatric ependymoma.
Savill R, Scotting PJ, and Coyle B. (2005) Strategies to investigate gene expression and function in cerebellar granule neurons Cerebellum 4, 271-8.
Coyle B, Freathy C, Gant TW, Roberts RA, Cain K. (2003). Characterization of the Transforming Growth Factor-beta 1-induced Apoptotic Transcriptome in FaO Hepatoma Cells. Journal of Biological Chemistry 278, 5920-8.